Angiotensin stimulates TGF-β1 and clusterin in the hydronephrotic neonatal rat kidney

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 278, Issue 3 47-3, 2000, Pages

  Yoo, Kee Hwan ^a   Thornhill, Barbara A ^b   Chevalier, Robert L ^b,c  

^a Korea University   (South Korea)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

AT1 receptors; AT2 receptors; Losartan; PD 123319

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; CLUSTERIN; LOSARTAN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ARTICLE; HYDRONEPHROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URETER OBSTRUCTION;

EID: 0343775774     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.278.3.r640     Document Type: Article

References (51)

1. Ando, T., S. Okuda, T. Yanagida, and M. Fujishima. Localization of TGF-β and its receptors in the kidney. Miner. Electrolyte Metab. 24: 149-153, 1998.
2. Ando, Y., Y. Isaka, M. Tsujii, Y. Akagi, Y. Kaneda, A. Yamauchi, A. Ando, N. Ueda, E. Imai, and M. Hori. Introduction of TGF-β antisense oligodeoxy-nucleotides into interstitial fibroblasts blocked tubulointerstitial fibrosis in unilateral ureteral obstruction rats (Abstract). J. Am. Soc. Nephrol. 9: 512A, 1998.
3. Basile, D. P., D. R. Martin, and M. R. Hammerman. Extracellular matrix-related genes in kidney after ischemic injury: potential role for TGF-β in repair. Am. J. Physiol. Renal Physiol. 275: F894-F903, 1998.
4. Bursch, W., F. Oberhammer, R. L. Jirtle, M. Askari, R. Sedivy, B. Grasl-Kraupp, A. F. Purchio, and R. Schulte-Hermann. Transforming growth factor-β1 as a signal for induction of cell death by apoptosis. Br. J. Cancer 67: 531-536, 1993.
5. Chevalier, R. L. Growth factors and apoptosis in neonatal ureteral obstruction. J. Am. Soc. Nephrol. 7: 1098-1105, 1996.
6. Chevalier, R. L., K. H. Chung, C. D. Smith, M. Ficenec, and R. A. Gomez. Renal apoptosis and clusterin following ureteral obstruction: the role of maturation. J. Urol. 156: 1474-1479, 1996.
7. Chevalier, R. L., S. Goyal, J. T. Wolstenholme, and B. A. Thornhill. Obstructive nephropathy in the neonatal rat is attenuated by epidermal growth factor. Kidney Int. 54: 38-47, 1998.
8. Chevalier, R. L., A. Kim, B. A. Thornhill, and J. T. Wolstenholme. Recovery following relief of unilateral ureteral obstruction in the neonatal rat. Kidney Int. 55: 793-807, 1999.
9. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
10. Chung, K. H., and R. L. Chevalier. Arrested development of the neonatal kidney following chronic ureteral obstruction. J. Urol. 155: 1139-1144, 1996.
11. 1 receptors during neonatal ureteral obstruction. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 268: F1117-F1123, 1995.
12. Chung, O., H. Kuehl, M. Stoll, and T. Unger. Physiological and pharmacological implications of AT1 vs. AT2 receptors. Kidney Int. 54, Suppl 67: S95-S99, 1998.
13. Davidson, J. M., and K. N. Broadley. Manipulation of the wound-healing process with basic fibroblast growth factor. Ann. NY Acad. Sci. 638: 306-315, 1991.
14. Fern, R. J., C. M. Yesko, B. A. Thornhill, H.-S. Kim, O. Smithies, and R. L. Chevalier. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J. Clin. Invest. 103: 39-46, 1999.
15. French, L. E., A. Wohlwend, A. P. Sappino, J. Tschopp, and J. A. Schifferli. Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J. Clin. Invest. 93: 877-884, 1994.
16. Frisch, S. M., and H. Francis. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124: 619-626, 1994.
17. Frishberg, Y., and C. J. Kelly. TGF-β and regulation of interstitial nephritis. Miner. Electrolyte Metab. 24: 181-189, 1998.
18. Fukuda, N., W.-Y. Hu, A. Kubo, M. Endoh, H. Kishioka, C. Satoh, M. Soma, Y. Izumi, and K. Kanmatsuse. Abnormal regulation of transforming growth factor-beta receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II. Hypertension 31: 672-677, 1998.
19. Gibbons, G. H., R. E. Pratt, and V. J. Dzau. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-β1 expression determines growth response to angiotensin II. J. Clin. Invest. 90: 456-461, 1992.
20. Gomez, R. A., K. R. Lynch, B. C. Sturgill, J. P. Elwood, R. L. Chevalier, R. M. Carey, and M. J. Peach. Distribution of renin mRNA and its protein in the developing kidney. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 257: F850-F858, 1989.
21. Harris, R. C., Y. Akai, T. Yasuda, and T. Homma. Role of physical factors in the regulation of mesangial cell growth and the interaction with vasoactive agents. Exp. Nephrol. 2: 104, 1994.
22. Heino, J., R. A. Ignotz, M. E. Hemler, C. Crouse, and J. Massague. Regulation of cell adhesion receptors by transforming growth factor-β. J. Biol. Chem. 264: 380-388, 1989.
23. Ishidoya, S., J. Morrissey, R. McCracken, A. Reyes, and S. Klahr. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int. 47: 1285-1294, 1995.
24. Jin, G., and P. H. Howe. Regulation of clusterin gene expression by transforming growth factor-β. J. Biol. Chem. 272: 26620-26626, 1997.
25. Kuizinga, M. C., J. M. Smits, J. W. Arends, and M. P. Daemen. AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J. Mol. Cell. Cardiol. 30: 425-434, 1998.
26. Levy, B. I., J. Benessiano, D. Henrion, L. Caputo, C. Heymes, M. Duriez, P. Poitevin, and J. L. Samuel. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J. Clin. Invest. 98: 418-425, 1996.
27. Mauch, T. J., G. Yang, E. Howe, K. M. Baker, and D. E. Dostal. Determination of renin-angiotensin system component mRNA levels in developing rat kidney using multiplex polymerase chain reaction (Abstract). J. Am. Soc. Nephrol. 8: 363A, 1997.
28. Medjebeur, A. A., L. Bussieres, B. Gasser, V. Gimonet, and K. Laborde. Experimental bilateral urinary obstruction in fetal sheep: transforming growth factor-β1 expression. Am. J. Physiol. Renal Physiol. 273: F372-F379, 1997.
29. Nelson, K. G., T. Takahashi, N. L. Bossert, D. K. Walmer, and J. A. McLachlan. Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc. Natl. Acad. Sci. USA 88: 21-25, 1991.
30. Nguyen, H. T., A.A. Thomson, B. A. Kogan, L. S. Baskin, and G. R. Cunha. Growth factor expression in the obstructed developing and mature rat kidney. Lab. Invest. 79: 171-184, 1999.
31. Niimura, F., P. A. Labosky, J. Kakuchi, S. Okubo, H. Yoshida, T. Oikawa, T. Ichiki, A. J. Naftilan, A. Fogo, T. Inagami, B. L. M. Hogan, and I. Ichikawa. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J. Clin. Invest. 96: 2947-2954, 1995.
32. Ozono, R., Z. Q. Wang, A. F. Moore, T. Inagami, H. M. Siragy, and R. M. Carey. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30: 1238-1246, 1997.
33. 1 receptor. Am. J. Physiol. Renal Fluid Electrolyte Physiol. 264: F989-F995, 1993.
34. Pimentel, J. L., Jr., C. L. Sundell, S. S. Wang, J. B. Kopp, A. Montero, and M. Martinez-Maldonado. Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int. 48: 1233-1246, 1995.
35. Reddy, K. B., G. Jin, M. C. Karode, J. A. K. Harmony, and P. H. Howe. Transforming growth factor-β (TGF-β)-induced localization of apolipoprotein J/clusterin in epithelial cells. Biochemistry 35: 6157-6163, 1996.
36. Reddy, K. B., M. C. Karode, J. A. K. Harmony, and P. H. Howe. Interaction of transforming growth factor-β receptors with apolipoprotein J/clusterin. Biochemistry 35: 309-314, 1996.
37. Roberts, A. B., B. K. McCune, and M. B. Sporn. TGF-β: regulation of extracellular matrix. Kidney Int. 41: 557-559, 1992.
38. Ruiz-Ortega, M., and J. Egido. Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int. 52: 1497-1510, 1997.
39. Schwochau, G. B., K. A. Nath, and M. E. Rosenberg. Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. Kidney Int. 53: 1647-1653, 1998.
40. Siegel, S. R. Decreased vascular and increased adrenal and renal sensitivity to angiotensin II in the newborn lamb. Circ. Res. 48: 34-38, 1981.
41. Silkensen, J. R., K. M. Skubitz, A. P. N. Skubitz, D. H. Chmielewski, J. C. Manivel, J. A. Dvergsten, and M. E. Rosenberg. Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells. J. Clin. Invest. 96: 2646-2653, 1995.
42. Stagner, J. I., and E. Samois. The induction of capillary bed development by endothelial cell growth factor before islet transplantation may prevent islet ischemia. Transplant. Proc. 22: 824-828, 1990.
43. Tanaka, M., J. Ohnishi, Y. Ozawa, M. Sugimoto, S. Usuki, M. Naruse, K. Murakami, and H. Miyazaki. Characterization of angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells. Biochem. Biophys. Res. Commun. 207: 593-598, 1995.
44. Tsukada, T., K. Eguchi, K. Migita, Y. Kawabe, A. Kawakami, N. Matsuoka, H. Takashima, A. Mizokami, and S. Nagataki. Transforming growth factor-β1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem. Biophys. Res. Commun. 210: 1076-1082, 1995.
45. Van Zoelen, E. J. J., and L. G. J. Tertoolen. Transforming growth factor-β enhances the extent of intercellular communication between normal rat kidney cells. J. Biol. Chem. 266: 12075-12081, 1991.
46. Wong, P. C., T. B. Barnes, A. T. Chiu, D. D. Christ, J. V. Duncia, W. F. Herblin, and P. B. M. W. M. Timmermans. Losartan (DuP 753), an orally active nonpeptide angiotensin II receptor antagonist. Cardiovasc. Drug Rev. 9: 317-339, 1991.
47. Yamada, T., M. Horiuchi, and V. J. Dzau. Angiotensin II type 2 receptor mediates programmed cell death. Proc. Natl. Acad. Sci. USA 93: 156-160, 1996.
48. 2 receptors in neonatal ureteral obstruction. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 273: R503-R509, 1997.
49. Yoo, K. H., B. A. Thornhill, J. T. Wolstenholme, and R. L. Chevalier. Tissue-specific regulation of growth factors and clusterin by angiotensin II. Am. J. Hypertens. 11: 715-722, 1998.
50. Yoo, K. H., J. T. Wolstenholme, and R. L. Chevalier. Angiotensin-converting enzyme inhibition decreases growth factor expression in the neonatal rat kidney. Pediatr. Res. 42: 588-592, 1997.
51. Young, M. R. A., I. S. Young, S. R. Johnston, and B. J. Rowlands. Lipid peroxidation assessment of free radical production following release of obstructive uropathy. J. Urol. 156: 1828-1832, 1996.